Ipsen and Medetia join forces to accelerate early research in rare disease - Global
Ipsen: a dynamic, fast-growing specialty care powerhouse
Ipsen CEO David Loew is elected to EFPIA leadership; joins industry partners to warn of impact of EU pharma legislation - Global
Ipsen to acquire exclusive rights to investigational ERK inhibitor as part of its existing research collaboration with AGV Discovery | Liberi Group
Ipsen (@IpsenGroup) / X
FOP Fnd NL on X: "Ipsen Initiates Partial Clinical Hold for Palovarotene IND120181 and IND135403 Studies ...for children under the age of 14 because of some cases with early growth plate closure...
Press Releases - Ipsen UK
Press Releases - Ipsen UK
IPSEN: Announces FDA Approval of Dysport® (abobotulinumtoxinA) for the Treatment of Upper Limb Spasticity in Children, Excluding Cerebral Palsy | FDA Reporter
Ipsen to acquire Albireo accelerating growth in rare disease with treatments for several pediatric liver diseases
Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership
Merrimack Provides Ipsen Report That Onivyde® Regimen Demonstrated Statistically Significant Improvement in Overall Survival in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Press releases
Ipsen Goes All In on Neuro with $1 Billion+ Deal For Exicure's Oligonucleotides | BioSpace
Global Biopharmaceutical Company, Ipsen Announces New Headquarters for North America will be located in Cambridge, Massachusetts | Financial Post
Gebrüder Weiss takes over Ipsen Logistics' Air & Sea business | DC Velocity
Ipsen CEO steers clear of gene therapy despite rare disease push
Pharma News and Updates | Ipsen, BioMarin, AbbVie, BMS, GSK, Novartis
Ipsen is officially recognized as a great place to work worldwide - Global
06-01-2016-PR-Ipsen-Galderma-APAC-Dysport-Aesthetics
Press Releases - Ipsen UK
Mayoly Spindler completed the acquisition of Ipsen's CHC branch - MAYOLY SPINDLER laboratoire indépendant français
Combined Shareholders' Meeting of 27 May 2021
LeaveRussia: Ipsen is Pausing New Investments in Russia
